Literature DB >> 30811996

Unbiased Profiling of Isogenic Huntington Disease hPSC-Derived CNS and Peripheral Cells Reveals Strong Cell-Type Specificity of CAG Length Effects.

Jolene Ooi1, Sarah R Langley2, Xiaohong Xu3, Kagistia H Utami1, Bernice Sim1, Yihui Huang1, Nathan P Harmston4, Yi Lin Tay1, Amin Ziaei1, Ruizhu Zeng1, Donovan Low5, Folefac Aminkeng1, Radoslaw M Sobota6, Florent Ginhoux5, Enrico Petretto4, Mahmoud A Pouladi7.   

Abstract

In Huntington disease (HD), the analysis of tissue-specific CAG repeat length effects has been challenging, given the difficulty in obtaining relevant patient tissues with a broad range of CAG repeat lengths. We used genome editing to generate an allelic panel of isogenic HD (IsoHD) human embryonic stem cell (hESC) lines carrying varying CAG repeat lengths in the first exon of HTT. Functional analyses in differentiated neural cells revealed CAG repeat length-related abnormalities in mitochondrial respiration and oxidative stress and enhanced susceptibility to DNA damage. To explore tissue-specific effects in HD, we differentiated the IsoHD panel into neural progenitor cells, neurons, hepatocytes, and muscle cells. Transcriptomic and proteomic analyses of the resultant cell types identified CAG repeat length-dependent and cell-type-specific molecular phenotypes. We anticipate that the IsoHD panel and transcriptomic and proteomic data will serve as a versatile, open-access platform to dissect the molecular factors contributing to HD pathogenesis.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CAG repeat; DNA damage; Huntington disease; differentiation; genome editing; human stem cells; isogenic; mitochondria; proteomics; transcriptome

Mesh:

Substances:

Year:  2019        PMID: 30811996     DOI: 10.1016/j.celrep.2019.02.008

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  19 in total

1.  Brain microvascular endothelial cell dysfunction in an isogenic juvenile iPSC model of Huntington's disease.

Authors:  Raleigh M Linville; Renée F Nerenberg; Gabrielle Grifno; Diego Arevalo; Zhaobin Guo; Peter C Searson
Journal:  Fluids Barriers CNS       Date:  2022-06-30

2.  Standardization of Cell Culture Conditions and Routine Genomic Screening under a Quality Management System Leads to Reduced Genomic Instability in hPSCs.

Authors:  Francisco J Molina-Ruiz; Clelia Introna; Georgina Bombau; Mireia Galofre; Josep M Canals
Journal:  Cells       Date:  2022-06-21       Impact factor: 7.666

Review 3.  Huntington's disease iPSC models-using human patient cells to understand the pathology caused by expanded CAG repeats.

Authors:  Julia Kaye; Terry Reisine; Steven Finkbeiner
Journal:  Fac Rev       Date:  2022-06-28

Review 4.  Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells.

Authors:  Swati Naphade; Kizito-Tshitoko Tshilenge; Lisa M Ellerby
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

5.  Aberrant Development Corrected in Adult-Onset Huntington's Disease iPSC-Derived Neuronal Cultures via WNT Signaling Modulation.

Authors:  Charlene Smith-Geater; Sarah J Hernandez; Ryan G Lim; Miriam Adam; Jie Wu; Jennifer T Stocksdale; Brook T Wassie; Maxwell Philip Gold; Keona Q Wang; Ricardo Miramontes; Lexi Kopan; Iliana Orellana; Shona Joy; Paul J Kemp; Nicholas D Allen; Ernest Fraenkel; Leslie M Thompson
Journal:  Stem Cell Reports       Date:  2020-02-27       Impact factor: 7.765

Review 6.  Molecular Mechanisms Underlying Muscle Wasting in Huntington's Disease.

Authors:  Manuela Bozzi; Francesca Sciandra
Journal:  Int J Mol Sci       Date:  2020-11-05       Impact factor: 5.923

7.  CAG repeat instability in embryonic stem cells and derivative spermatogenic cells of transgenic Huntington's disease monkey.

Authors:  Sujittra Khampang; Rangsun Parnpai; Wiriya Mahikul; Charles A Easley; In Ki Cho; Anthony W S Chan
Journal:  J Assist Reprod Genet       Date:  2021-02-20       Impact factor: 3.412

Review 8.  Juvenile Huntington's Disease and Other PolyQ Diseases, Update on Neurodevelopmental Character and Comparative Bioinformatic Review of Transcriptomic and Proteomic Data.

Authors:  Karolina Świtońska-Kurkowska; Bart Krist; Joanna Delimata; Maciej Figiel
Journal:  Front Cell Dev Biol       Date:  2021-07-01

9.  Generation of New Isogenic Models of Huntington's Disease Using CRISPR-Cas9 Technology.

Authors:  Magdalena Dabrowska; Agata Ciolak; Emilia Kozlowska; Agnieszka Fiszer; Marta Olejniczak
Journal:  Int J Mol Sci       Date:  2020-03-08       Impact factor: 5.923

10.  The interplay between redox signalling and proteostasis in neurodegeneration: In vivo effects of a mitochondria-targeted antioxidant in Huntington's disease mice.

Authors:  Brígida R Pinho; Ana I Duarte; Paula M Canas; Paula I Moreira; Michael P Murphy; Jorge M A Oliveira
Journal:  Free Radic Biol Med       Date:  2019-11-18       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.